These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 7604785

  • 1. Is endothelial dysfunction reversible?
    Schmieder RE, Schobel HP.
    Am J Cardiol; 1995 Jul 13; 76(2):117A-121A. PubMed ID: 7604785
    [Abstract] [Full Text] [Related]

  • 2. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease.
    Eichstädt HW, Eskötter H, Hoffman I, Amthauer HW, Weidinger G.
    Am J Cardiol; 1995 Jul 13; 76(2):122A-125A. PubMed ID: 7604786
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of statins on vascular endothelial function in hypercholesterolemic patients with type 2 diabetes mellitus: fluvastatin vs. rosuvastatin.
    Tomizawa A, Hattori Y, Suzuki K, Okayasu T, Kase H, Satoh H, Kasai K.
    Int J Cardiol; 2010 Sep 24; 144(1):108-9. PubMed ID: 19174316
    [No Abstract] [Full Text] [Related]

  • 9. Outcome monitoring of fluvastatin in a Department of Veterans Affairs lipid clinic.
    Kellick KA, Burns K, McAndrew E, Haberl E, Hook N, Ellis A.
    Am J Cardiol; 1995 Jul 13; 76(2):62A-64A. PubMed ID: 7604801
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group.
    Bard JM, Ose L, Hagen E, Duriez P, Pfister P, Fruchart JC, Dallongeville J.
    Am J Cardiol; 1995 Jul 13; 76(2):65A-70A. PubMed ID: 7604802
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. FLUENT Study Group. Fluvastatin Long-Term Extension Trial.
    Zavoral JH, Haggerty BJ, Winick AG, Bergmann SD.
    Am J Cardiol; 1995 Jul 13; 76(2):37A-40A. PubMed ID: 7604795
    [Abstract] [Full Text] [Related]

  • 17. Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia.
    Milani M, Cimminiello C, Merlo B, Lorena M, Arpaia G, Bonfardeci G.
    Am J Cardiol; 1995 Jul 13; 76(2):51A-53A. PubMed ID: 7604798
    [Abstract] [Full Text] [Related]

  • 18. Fluvastatin versus pravastatin.
    Chilton R.
    Am J Cardiol; 1996 Jul 01; 78(1):127. PubMed ID: 8712106
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of triple therapy (fluvastatin-bezafibrate-cholestyramine) for severe familial hypercholesterolemia.
    Leitersdorf E, Muratti EN, Eliav O, Peters TK.
    Am J Cardiol; 1995 Jul 13; 76(2):84A-88A. PubMed ID: 7604807
    [Abstract] [Full Text] [Related]

  • 20. Fluvastatin for lowering cholesterol.
    Med Lett Drugs Ther; 1994 May 27; 36(923):45-6. PubMed ID: 8177137
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.